Myriad Genetics Inc (NASDAQ:MYGN)

23.42
Delayed Data
As of Jun 02
 +0.32 / +1.39%
Today’s Change
13.92
Today|||52-Week Range
28.18
+61.41%
Year-to-Date
Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio
May 25 / Zacks.com - Paid Partner Content